ArticleClinical lymphoma, myeloma & leukemia2021

Dramatic Response to Convalescent Hyperimmune Plasma in Association With an Extended Course of Remdesivir in 4 B Cell-Depleted Non-Hodgkin Lymphoma Patients With SARS-Cov-2 Pneumonia After Rituximab Therapy.

Anna Furlan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.